13F-HR filed by Ishara Investments LP
Ishara Investments LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 37 holding rows worth $105,625,159.
- Accession
- 0002111609-26-000002
- Filer
- CIK 2111609
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 37 entries on the cover page, a total value of $105,625,159 stated on the cover page (in dollars after the unit check, H1), rows summing to $105,625,159 with VALUE read as dollars as filed, 13F file number 028-26490. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 22,550 | $7,265,385 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 41,000 | $6,929,820 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 20,500 | $6,604,895 | dollars as filed | put |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 1,025,000 | $5,945,000 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 276,750 | $5,570,978 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 369,000 | $5,335,740 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 82,000 | $4,632,180 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 820,000 | $4,346,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 174,250 | $3,650,538 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 55,350 | $3,470,445 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 57,400 | $3,335,514 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 82,000 | $3,298,860 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 110,700 | $3,288,897 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 174,250 | $3,248,020 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 1,230,000 | $2,878,200 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 57,400 | $2,821,784 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 123,000 | $2,737,980 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 451,000 | $2,701,490 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 82,000 | $2,221,380 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 82,000 | $2,200,060 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 102,500 | $2,141,225 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 82,000 | $2,030,320 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 49,200 | $1,972,428 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 142,000 | $1,854,520 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 5,125 | $1,695,709 | dollars as filed | |
| LIGAND PHARMACEUTICALS INC | 53220K504 | COM NEW | 8,200 | $1,637,130 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 49,200 | $1,549,800 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 153,750 | $1,512,900 | dollars as filed | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 902,000 | $1,407,120 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 57,400 | $1,367,842 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 102,500 | $1,298,675 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 36,900 | $1,181,169 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 174,250 | $965,345 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 24,600 | $819,672 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 140,500 | $740,435 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 10,250 | $698,333 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 820,000 | $269,370 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002111609-26-000002 | this filing | 2026-05-15 | acceptance time not in the bulk data set |